top of page

PUBLICATIONS

25. Balsamo, J. M.; Yan, Y.; Thai, D.; Cologna, S. M.*; Bess, E. N.* Multiomic Analysis Reveals Molecular Pathways Associated with Intestinal Aggregation of α-Synuclein. ACS Chem. Biol., 2026, 21, 83–95.

Bacteria in gut lumen adjacent to enteroendocrine cell wherein L-dopa is converted to dopamine and with Fe2+, alpha-syn and NO2- results in alpha-synuclein aggregation

24. Alam, Y.; Hakopian, S.; Ortiz de Ora, L.; Tamburini, I.; Avelar-Barragan, J.; Jung, S. ; Long, Z.; Chao, A.; Whiteson, K.; Jang, C.*; Bess, E. N.* Variation in Human Gut Microbiota Impacts Tamoxifen Pharmacokinetics. mBio2024, doi:10.1128/mbio.01679-24Editor's Pick News Release.

Pro-drug tamoxifen converted by liver P450s and UDP to endoxifen glucuronide that is then convered to bioactive endoxifen by gut bacteria. Graph showing that gut bacteria elevate the concentration of bioactive drug in the bloodstream.
Electrodes measuring dopamine current and dopamine leads to alpha-synuclein aggregation while other catechol molecules prevent aggregation

23. Balsamo, J. M. ; Zhou, K.; Kammarchedu, V.; Ebrahimi, A.*; Bess, E. N.* Mechanistic Insight into Intestinal α-Synuclein Aggregation in Parkinson’s Disease Using a Laser-Printed Electrochemical Sensor. ACS Chemical Neuroscience, 2024. 15, 2623–2632.

 

22. Kyaw, T.S.; Zhang, C.; Sandy, M.; Trepka, K.; Zhang, S.; Ramirez Hernande, LA.; Ramirez, .; Goh, J.J.N.; Yu, K.; Dimassa, V.; Bess, E.N.; Brockert, J.G.; Dumlao, D.S.; Bisanz, J.E.; Turnbaugh, P.J. Human Gut Actinobacteria Boost Drug Absorption by Secreting P-Glycoprotein ATPase Inhibitors. iScience2024, doi: 10.1016/j.isci.2024.110122.

 

21. Ortiz de Ora, L.; Balsamo, J. M.; Uyeda, K. S.; Bess, E. N.* Discovery of a Gut Bacterial Metabolic Pathway that Drives α-Synuclein Aggregation. ACS Chemical Biology, 2024, 19, 1011-1021.

Dopamine, Fe2+, and alpha-syn monomer with the addition of NO2- produced from NO3- by Enterobacteriaceae bacteria are transformed to neurotoxic alpha-syn aggregates

20. Rich, B.E.; Jackson, J. C.; Ortiz de Ora, L.; Long, Z. G.; Uyeda, K. S.; Bess. E. N.* Alternative Pathway for Dopamine Production by Acetogenic Gut Bacteria that O-Demethylate 3-Methoxytyramine, a Metabolite of Catechol O-Methyltransferase. J. Appl. Microbiol., 2022. 133, 1697-1708.

Dopamine is converted by liver COMT to 3-methoxytyramine that is then reverted back to dopamine by gut microbiota (Eubacterium limosum, Blautia producta) with acetate produced as a byproduct.

19. Ortiz de Ora, L.; Bess, E. N.* Emergence of C. elegans as a Model Organism for Dissecting the Gut–Brain Axis. mSystems20216, e00755-21.

18. Maini Rekdal, V.; Bernadino, P. N.; Luescher, M. U.; Kiamehr, S.; Le, C.; Bisanz,  J. E.; Turnbaugh, P. J.; Bess, E. N.; Balskus, E. P. A Widely Distributed Metalloenzyme Class Enables Gut Microbial Metabolism of Host- and Diet-Derived Catechols. eLife20209, e50845.

17. Bisanz, J. E.; Soto-Perez, P.; Noecker, C.; Aksenov, A.; Lam, K. N.; Kenney, G. E.; Bess, E. N.; Haiser, H. J.; Kyaw, T. S.; Yu, F. B.; Rekdal, V. M.; Ha, C. W. Y.; Devkota, S.; Balskus, E. P.; Dorrestein, P. C.; Allen-Vercoe, E.; Turnbaugh, P. J. A Genomic Toolkit for the Mechanistic Dissection of Intractable Human Gut Bacteria. Cell Host Microbe 2020, 27, 1001-1013.e9.

​

16. Bess, E. N.; Bisanz, J.; Yarza, F.; Bustion, A.; Rich, B. E.; Li, X.; Kitamura, S.; Waligurski, E.; Ang, Q. Y.; Alba, D. L.; Spanogiannopoulos, P.; Nayfach, S.; Koliwad, S. K.; Wolan, D. W.; Franke, A. A.; Turnbaugh, P. J. Genetic Basis for the Cooperative Bioactivation of Plant Lignans by Eggerthella lenta and Other Human Gut Bacteria. Nature Micro. 2020, 5, 56–66.

​

15. Carmody, R.; Bisanz, B.; Bowen, B.; Maurice, C.; Lyalina, S.; Louie, K.; Treen, D.; Chadaideh, K.; Rekdal, V.; Bess, E. N.; Spanogiannopoulos, P.; Ang, Q. Y.; Bauer, K.; Balon, T.; Pollard K.; Northen, T.; Turnbaugh, T. Cooking Shapes the Structure and Function of the Gut Microbiome. Nature Micro. 2019, 4, 2052–2063.

​

14. Maini Rekdal, V.; Bess, E. N.; Bisanz, J. E.; Turnbaugh, P. J.; Balskus, E. P. Discovery and Inhibition of an Interspecies Gut Bacterial Pathway for Levodopa Metabolism. Science 2019364, eaau6323.

​

13. Spanogiannopoulos, P.; Bess, E. N.; Carmody, R. N.; Turnbaugh, P. J. The Microbial Pharmacists Within: A Metagenomic View of Xenobiotic Metabolism. Nature Rev. Microbiol. 2016, 14, 273–287.

​

12. Sigman, M. S.; Harper, K. C.; Bess, E. N.; Milo, A. The Development of Multidimensional Analysis Tools for Asymmetric Catalysis and Beyond. Acc. Chem. Res. 2016, 49, 1292–1301.

​

11. Mougel, V.; Santiago, C. B.; Zhizhko, P. A.; Bess, E. N.; Varga, J.; Frater, G.; Sigman, M. S.; Coperet, C. Quantitatively Analyzing Metathesis Catalyst Activity and Structural Features in Silica-Supported Tungsten Imido-Alkylidene Complexes. J. Am. Chem. Sci. 2015, 137, 6699–6704.

​

10. Bess, E. N.; Guptill, D.; Davies, H. M. L.; Sigman, M. S. Using IR Vibrations to Quantitatively Describe and Predict Site-Selectivity in Multivariate Rh-Catalyzed C–H Functionalization. Chem. Sci. 2015, 6, 3057–3062.

​

9. Bess, E. N.; Bischoff, A. J.; Sigman, M. S. Designer Substrate Library for Quantitative, Predictive Modeling of Reaction Performance. Proc. Natl. Acad. Sci. U.S.A. 2014, 111, 14698–14703.

​

8. Bess, E. N.; DeLuca, R. J.; Tindall, D. J.; Oderinde, M. S.; Roizen, J. L.; Du Bois, J.; Sigman, M. S. Analyzing Site Selectivity in Rh2(esp)2-Catalyzed Intermolecular C–H Amination Reactions. J. Am. Chem. Soc. 2014, 136, 5783–5789.

​

7. Milo, A.; Bess, E. N.; Sigman, M. S. Interrogating Selectivity in Catalysis using Molecular Vibrations. Nature 2014, 507, 210–214.

​

6. Bess, E. N.; Sigman, M. S. Distinctive Meta-Directing Group Effect for Iridium-Catalyzed 1,1-Diarylalkene Enantioselective Hydrogenation. Org. Lett. 2013, 15, 646–649. Highlighted in Angew. Chem. Int. Ed. 2013, 52, 8795-8797.

​

5. Bess, E. N.; Sigman, M. S. Linear Free Energy Relationships (LFERs) in Asymmetric Catalysis. In Asymmetric Synthesis II: More Methods and Applications, Christmann, M.; Bräse, S., Eds. Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, 2012; pp 363–370.

​

4. Harper, K. C.; Bess, E. N.; Sigman, M. S. Multidimensional Steric Parameters in the Analysis of Asymmetric Catalytic Reactions. Nature Chem. 2012, 4, 366–374.

​

3. Sherwood, K.; Sugerman, S.; Bossart, P.; Bledsoe, J.; Barton, E.; Bernhisel, K.; Bess, E.; Madsen, T. EDOU Staffing by PAs: What are the Effects on Patient Outcomes? JAAPA 2011, 24, 31–37.

​

2. Lingenfelter, E. M.; Davis, V.; Larrabee, K.; Bess, E.; Canning, P.; Madsen, T. 192: Cholesterol Screening and Intervention Compliance In Chest Pain Patients In the Emergency Department Observation Unit Setting. Ann. Emerg. Med. 2010, 56, S64.

​

1. Bledsoe, J.; Hamilton, D.; Bess, E.; Holly, J.; Sturges, Z.; Madsen, T. Treatment of Low-risk Pulmonary Embolism Patients in a Chest Pain Unit. Crit. Pathw. Cardiol. 2010, 9, 212–215.

© 2026 by The Bess Lab.

bottom of page